Premenstrual Syndromes : PMS and PMDD - Rutuja :: The site ...

69. Studd J, Leather AT. The need for add-back with gonadotrophinreleasing
hormone agonist therapy. Br J Obstet Gynaecol 1996;
103(Suppl 14):1–4.
70. Hahn PM, Van Vugt DA, Reid RL. A randomized, placebocontrolled,
crossover trial of danazol for the treatment of premenstrual
syndrome. Psychoneuroendocrinology 1995; 20:193–209.
71. Deeny M, Hawthorn R, McKay HD. Low dose danazol in the
treatment of the premenstrual syndrome. Postgrad Med J 1991;
67:450–4.
72. Wyatt K, Dimmock P, Jones P et al. Efficacy of progesterone and
progestogens in management of premenstrual syndrome: systematic
review. BMJ 2001; 323:776–80.
73. Watson NR, Studd JW, Savvas M et al. Treatment of severe premenstrual
syndrome with oestradiol patches and cyclical oral
norethisterone. Lancet 1989; 2:730–2.
74. Taskin O, Gokdeniz R, Yalcinoglu A et al. Placebo-controlled
cross-over study of effects of tibolone on premenstrual symptoms
and peripheral beta-endorphin concentrations in premenstrual
syndrome. Hum Reprod 1998; 13:2402–5.
75. Stevinson C, Ernst E. Complementary/alternative therapies for
premenstrual syndrome: a systematic review of randomized
controlled trials. Am J Obstet Gynecol 2001; 185:227–35.
76. Lam RW, Carter D, Misri S et al. A controlled study of light
therapy in women with late luteal phase dysphoric disorder.
Psychiatry Res 1999; 86(3):185–92.
CLINICAL EVALUATION AND MANAGEMENT 159
77. Krasnik C, Montori VM, Guyatt GH et al.; Medically
Unexplained Syndromes Study Group. The effect of bright light
therapy on depression associated with premenstrual dysphoric
disorder. Am J Obstet Gynecol 2005; 193:658–61.
78. Steinberg S, Annable L, Young SN et al. A placebo-controlled
clinical trial of L-tryptophan in premenstrual dysphoria. Biol
Psychiatry 1999; 45:313–20.
79. Wuttke W, Jarry H, Christoffel V et al. Chaste tree (Vitex
agnus-castus) – pharmacology and clinical indications. Phytomedicine
2003; 10(4):348–57.
80. Schellenberg R. Treatment for the premenstrual syndrome with
agnus castus fruit extract: prospective, randomised, placebo
controlled study. BMJ 2001; 322(7279):134–7.
81. Casper RF, Hearn MT. The effect of hysterectomy and bilateral
oophorectomy in women with severe premenstrual syndrome.
Am J Obstet Gynecol 1990; 162:105–9.
82. Casson P, Hahn PM, Van Vugt DA et al. Lasting response to
ovariectomy in severe intractable premenstrual syndrome. Am J
Obstet Gynecol 1990; 162:99–105.
83. Parker WH, Broder MS, Liu Z et al. Ovarian conservation at the
time of hysterectomy for benign disease. Obstet Gynecol 2005;
106(2):219–26.